(Q43870639)

27 November 2017

Studies on modulation of feeding behavior by atypical antipsychotics in female mice (English)

1 reference

27 November 2017

Gurpreet Kaur

1

1 reference

PubMed ID

11817504

27 November 2017

Shrinivas K Kulkarni

series ordinal

2

1 reference

27 November 2017

1 February 2002

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

27 November 2017

1 reference

27 November 2017

26

1 reference

27 November 2017

2

1 reference

27 November 2017

277-285

1 reference

Body weight gain induced by antipsychotic drugs: mechanisms and management

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Long term administration of some antipsychotic drugs increases body weight and feeding in rats. Are D2 dopamine receptors involved?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Antipsychotic drugs and reproductive hormones: relationship to body weight regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Possible clozapine exacerbation of bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Weight changes during clozapine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Competitive antagonism of serotonin (5-HT)2C and 5-HT2A receptor-mediated phosphoinositide (PI) turnover by clozapine in the rat: a comparison to other antipsychotics

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Food palatability and hunger modulated effects of CGS 9896 and CGS 8216 on food intake

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Phase-IV multicentre clinical study of risperidone in the treatment of outpatients with schizophrenia. The RIS-CAN-3 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Stimulation and inhibition of food intake by the selective dopamine D2 agonist, N-0437: a meal pattern analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Dexfenfluramine. An updated review of its therapeutic use in the management of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Multiple serotonin receptors: opportunities for new treatments for obesity?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Effects of the dopamine D2 agonists lisuride and CQ 32-084 on rat feeding behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Analysis of dopamine D1 and D2 receptor involvement in d- and l-amphetamine-induced anorexia in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

A clinical trial of the efficacy and acceptability of D-fenfluramine in the treatment of neuroleptic-induced obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Too many chronic mentally disabled patients are too fat.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

D2 receptors in the ventrolateral striatum are involved in feeding behavior in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

5-HT1B agonists induce anorexia at a postsynaptic site

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Clozapine-induced weight gain: prevalence and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Pharmacological characterization of perifornical hypothalamic dopamine receptors mediating feeding inhibition in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

An investigation of the mechanism responsible for fluoxetine-induced hypophagia in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Effects of indorenate on food intake: a comparison with fenfluramine and amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Role of dopamine D-1 and D-2 receptor subtypes in mediating dopamine agonist effects on food consumption in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Effects of chronically administered fluoxetine and fenfluramine on food intake, body weight and the behavioural satiety sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Effect of quipazine, a selective 5-HT3 agonist, on dietary self-selection of different macronutrient diets in male and female rats

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Dynorphin-(1–13), dopamine and feeding in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Long-term treatment with chlorpromazine and haloperidol but not with sulpiride and clozapine markedly elevates neuropeptide Y-like immunoreactivity in the rat hypothalamus.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Mechanism of the body weight increase induced by systemic sulpiride

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Weight gain associated with risperidone

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Bodyweight change as an adverse effect of drug treatment. Mechanisms and management

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Evidence for 5-HT2 receptor mediation in quipazine anorexia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Prevalence of obesity in patients receiving depot antipsychotics

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Differential antagonism of the effects of dopamine D1-receptor agonists on feeding behavior in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

A comparison of the effects of the D1 receptor antagonists SCH 23390 and SCH 39166 on suppression of feeding behavior by the D1 agonist SKF38393.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Olanzapine: a novel atypical neuroleptic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Feeding stimulated by very low doses of d-amphetamine administered systemically or by microinjection into the striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

Evaluation of dopamine receptor involvement in rat feeding behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900266-4

7 January 2021

10.1016/S0278-5846(01)00266-4

Identifiers

DOI

1 reference

27 November 2017

1 reference

PubMed ID

11817504